x |
| EBITDA for Cell Therapeutics Reaches Four Year Low |
|
Stock Quote: (NCM:CTIC) |
| 11/20/2009 |
|
| 0.39 |
 +0.0048 |
+1.25% |
1,976,410 |
|
| EBITDA for Cell Therapeutics Reaches Four Year Low |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 20, 2009-Ebitda News reports that negative EBITDA for Cell Therapeutics, Inc. (NASDAQ:CTIC) for its quarter ended September 30, 2009 was $(26,546,000), a 397% deterioration over ... read full story |
|
|
|
|
